CDC Recommendations Fuel Production of Viral Transport Medium for COVID-19 Research
The demand for swab and viral transport medium has increased during the COVID-19 (coronavirus) pandemic. Since research institutes and labs have intensified their experiments for developing COVID-19 vaccines, companies in the swab and viral transport medium market have increased their production capacities to develop products useful for viral collection, maintenance, and culture. For instance, Innovative Research - a manufacturer of high quality and affordable research materials, developing viral transport medium to support global research in COVID-19.
Rapid antigen testing and molecular assay experiments have fueled the demand for swab and viral transport medium during the ongoing coronavirus crisis. Long-term freezers and direct fluorescent antibody (DVA) applications are creating incremental opportunities for companies in the swab and viral transport medium market. They are following CDC (Centers for Disease Control and Prevention) recommendations to develop the formulations of products.
Request a sample to get extensive insights into the Swab and Viral Transport Medium Market
Sterile Swabs Facilitate Minimal Contact of Healthcare Workers with COVID-19 Samples
Overwhelming repercussions of the COVID-19 outbreak are being experienced in various sectors. In order to stabilize business activities like before, there is an unprecedented demand for COVID-19 vaccines to revive economic growth worldwide. Hence, technologists at the Sree Chitra Triunal Institute for Medical Sciences and Technology (SCTIMST) and Mallelil Industries co-developed oral and nasal swabs for COVID-19 testing. Companies in the swab and viral transport medium market are increasing the availability of sterile and ready-to-use swabs for COVID-19 testing.
Since COVID-19 cases continue to rise in India, companies in the India swab and viral transport medium market are manufacturing polymeric foam-tipped swabs with flexible plastic handles to deliver efficient recovery of viral RNA. Improved specimen collection with minimum discomfort to patients is the key to develop oral and nasal swabs. However, minimal contact of healthcare workers with samples during packing is another important aspect of COVID-19 testing.
To understand how our report can bring difference to your business strategy, Ask for a brochure
Appropriate Specimen Collection Crucial for Influenza Diagnosis
Companies in the swab and viral transport medium market are innovating in kits containing vials, double-ended flocked swabs, antibiotics, and other items that inhibit bacterial or fungal contamination. They are focusing on improved formulation of Hanks solution to contain the reproduction of bacterial and fungal flora. Innovative viral transport medium products are bolstering growth of the swab and viral transport medium market, which is estimated to reach a value of US$ 2.2 Bn by 2030.
With the onset of the flu season, manufacturers are developing viral transport medium for influenza diagnostics. Influenza-related morbidity and mortality is a major concern in healthcare in western countries. Hence, manufacturers are increasing their R&D capabilities to manufacture swabs and viral transport medium that facilitates appropriate specimen collection for improved patient care.
Stuck in a neck-to-neck competition with other brands? Request a custom report on Swab and Viral Transport Medium Market
False Negatives and Reinfections Hamper Diagnosis of COVID-19 in Patients
The swab and viral transport medium market is projected to advance at a sluggish CAGR of ~3% during the forecast period. This is evident since the issue of false negatives and reinfection is surfacing in COVID-19 diagnosis. As such, healthcare professionals are facing issues to test performance and interpretation of COVID-19 testing, as the level of viral RNA in many cases is below the limit of detection. Hence, manufacturers in the swab and viral transport medium market are following CDC guidelines to develop products that facilitate appropriate specimen collection.
A good specimen collection leads to accurate results, thus improving clinical outcomes for COVID-19 testing. As such, nasopharyngeal (NP) swabs are being highly publicized for COVID-19 testing and is recommended by the CDC. On the other hand, manufacturers are developing nasal turbinate swabs and self-collected swabs for efficient collection of the coronavirus using saliva to diagnose the infection.
Strategic Agreements Strengthen Distribution of Swab and Viral Transport Medium
Companies in the swab and viral transport medium market are increasing efforts to develop FDA (Food & Drug Association)-approved products to gain global recognition. For instance, Hardy Diagnostics— an FDA-licensed manufacturer of medical devices for microbiological testing has introduced the Universal Transport Medium (UTM)® which is suitable for collection, maintenance, and long-term freeze storage of clinical specimens. Prolonged viability of organisms is highly preferred by researchers in swab and viral transport medium.
Manufacturers in the swab and viral transport medium market are innovating in products that facilitate rapid antigen testing, viral culture, and molecular-based assay. They are adopting the vertically integrated approach to manufacture swab and viral transport medium in order to gain complete control over the entire process. Companies are entering into strategic agreements to strengthen the distribution of products.
3D Printed Swab Gains Popularity for Cost-efficient Production Using Renewable Resources
The 3 dimensional (3D) printers are being used to produce cost-efficient nasopharyngeal swabs. Companies in the swab and viral transport medium market are using fused deposition modelling (FDM) printers to manufacture nasopharyngeal swab in a cost-efficient manner. Apart from hospital and retail pharmacies, manufacturers are now realizing the potential of online pharmacies. Hence, they are collaborating with e-Commerce giants to broaden their revenue streams.
Manufacturers are using FDA-approved biocompatible materials in swab such as polylactic acid (PLA) plastic filament. They are making use of renewable resources such as sugarcane and tapioca roots to produce 3D printed swab. On the other hand, companies are using flocking methods to electrostatically deposit small fibers of synthetic materials onto an adhesive-coated surface to produce nasopharyngeal swabs. In order to eliminate the need for adhesives, manufacturers are using mini blunt-ended hooks to secure polyester threads of nasopharyngeal swabs.
Analysts’ Viewpoint
The FDA has relaxed its regulations for the production of swab and viral transport medium used in COVID-19 diagnosis. However, there is a need for pandemic preparedness funding to develop technologies that are agile and quickly adapt to the introduction of new pathogens in the environment in the upcoming years. Hence, companies in the swab and viral transport medium market should invest in state-of-the-art facilities that prevent the shortage of products in future pandemic-like situations and cater to rapid testing applications. Manufacturers are increasing their portfolio in products that facilitate appropriate collection of chlamydia, ureaplasma, and mycoplasma that remain stable even at room temperature.
Swab and Viral Transport Medium Market: Overview
- According to Transparency Market Research’s latest research report on the global swab and viral transport medium market for the historical period 2018-2019 and the forecast period 2020-2030, increase in demand for swabs and viral transport medium, owing to COVID-19 pandemic is projected to drive the global swab and viral transport medium market in the near future
- According to the report, the global swab and viral transport medium market was valued at US$ 0.9 Bn in 2019 and is anticipated to expand at a CAGR of ~3% from 2020 to 2030
Increase in Demand for Swabs and Viral Transport Medium Owing to COVID-19 Pandemic : Key Driver of Swab and Viral Transport Medium Market
- According to the Centers for Disease Control and Prevention, as of January 21, 2020, the total cases of COVID-19 in the U.S. stood at 5,340,232 and total deaths at 168,696. Cases among healthcare personnel were 135,298 and 629 deaths.
- The COVID-19 pandemic has led to an unprecedented need of diagnostic reverse transcription-PCR (RT-PCR) testing
- The ideal way for taking the specimen type is a nasopharyngeal (NP) swab, which can be easily transported to a molecular microbiology laboratory in viral transport medium (VTM) and the swabs for the further examinations
- There are several low cost techniques such as saline, with RT-PCR and NAAT assays for respiratory pathogens and its analysis. These have been developed and the FDA has cleared for use with more complex transport media such as VTM and universal transport medium [UTM].
- Hence, increase in demand for swabs and viral transport medium, owing to COVID-19 pandemic is expected to drive the global swab and viral transport market
Surge in Government Initiatives for Infectious and Non-infectious Diseases: Major Driver of Swab and Viral Transport Medium Market
- Addressing the needs of patients with infectious and non-infectious diseases has become a priority for healthcare providers and government organizations across the globe
- Moreover, the U.S. Administration for Community Living, Department of Health and Human Services, offers sponsorship for various studies on sepsis. These government initiatives encourage the development of new therapies for the treatment of infectious diseases.
Increase in Geriatric Population: Major Driver of Swab and Viral Transport Medium Market
- According to the United Nations Department of Economic and Social Affairs, Population Division, globally, there were 703 million persons aged 65 or over in 2019
- Eastern and Southeastern Asia were home to a significantly large number of the world’s geriatric population of ~260 million, which is followed by Europe and Northern America over 200 million
- The global geriatric population over the next three decades is projected to more than double, reaching over 1.5 billion persons in 2050
- The largest increase, about 312 million individuals, is projected to occur in Eastern and Southeastern Asia growing from 261 million in 2019 to 573 million persons aged 65 years or over, in 2050
- According to data from World Population Prospects: the 2019 Revision, by 2050, one in six people in the world would be over age 65 (16%), up from one in 11 in 2019 (9%)
- According to the World Health Organization (WHO), 38 million children under the age of 5 were overweight or obese in 2019. In 2016, more than 1.9 billion adults aged 18 years and older were overweight. Of these, over 650 million adults were obese.
- Once considered a high-income country issue, overweight and obesity are presently on the rise in low- and middle-income countries, particularly in urban settings
- Thus, rise in geriatric and obese population drives diseases and swab and viral transport medium market
Swab and Viral Transport Medium Market: Competition Landscape
- This report profiles major players operating in the global swab and viral transport medium market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
- The global swab and viral transport medium market is moderately fragmented with the presence of a large number of leading players in the international market and several small players in regional markets. Top players hold a major share of the global swab and viral transport medium market.
- Prominent players operating in the global swab and viral transport medium market include -
- Thermo Fisher Scientific
- Becton
- Dickinson and Company
- MWE
- Titan Biotech Ltd
- COPAN Diagnostics Inc.
- MANTACC
- Puritan Medical Products
- YOCON Biology
- Trinity Biotech
- VIRCELL S.L.
- The report on the global swab & viral transport medium market discusses individual strategies, followed by company profiles of manufacturers of vaccines. The competition landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global swab and viral transport medium market.
Swab and Viral Transport Medium Market - Segmentation
|
Type |
|
|
Application |
|
|
End User |
|
|
Region |
|
Frequently Asked Questions
What is the total market worth of swabs and viral transport medium market?
Swabs and viral transport medium market to reach valuation of US$ 2.2 Bn by 2030
What is the anticipated CAGR of the swabs and viral transport medium market in the forecast period?
Swabs and viral transport medium market is anticipated to expand at a CAGR of ~3% from 2020 to 2030
What are the key driving factors for the growth of the swabs and viral transport medium market?
Swabs and viral transport medium market is driven by increase in demand for swabs and viral transport medium, owing to COVID-19 pandemic
Which region is expected to project the highest market share in the global swabs and viral transport medium market?
North America accounted for a significant share of the global swab and viral transport medium market
Who are the key players in the global swabs and viral transport medium market?
Key players in the global swab and viral transport medium market include Thermo Fisher Scientific, Becton, Dickinson and Company, MWE, Titan Biotech Ltd
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Swab and Viral Transport Medium Market
4. Market Overview
4.1. Introduction
4.1.1. Type Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Swab and Viral Transport Medium Market Analysis and Forecast, 2018–2030
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis
5. Key Insights
5.1. Regulatory Scenario by Region/Globally
5.2. Key Mergers & Acquisitions
6. Global Swab and Viral Transport Medium Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Swab and Viral Transport Medium Market Value Forecast, by Product, 2018–2030
6.3.1. Swab Type
6.3.1.1. Nasal Swabs
6.3.1.2. Nasopharyngeal Swabs
6.3.1.3. Throat Swabs
6.3.2. Transport Medium
6.4. Global Swab and Viral Transport Medium Market Attractiveness Analysis, by Product
7. Global Swab and Viral Transport Medium Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Swab and Viral Transport Medium Market Value Forecast, by Application, 2018–2030
7.3.1. Viral Infection Diagnosis
7.3.1.1. COVID-19
7.3.1.2. Influenza
7.3.1.3. Herpes Simplex Virus
7.3.1.4. Varicella-zoster Virus
7.3.1.5. Others
7.3.2. Others
7.4. Global Swab and Viral Transport Medium Market Attractiveness Analysis, by Application
8. Global Swab and Viral Transport Medium Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Swab and Viral Transport Medium Market Value Forecast, by End-user, 2018–2030
8.3.1. Hospitals & Clinics
8.3.2. Microbiology Laboratories
8.3.3. Diagnostic Laboratories
8.3.4. Others
8.4. Global Swab and Viral Transport Medium Market Attractiveness Analysis, by End-user
9. Global Swab and Viral Transport Medium Market Analysis and Forecast, by Region
9.1. 10.1. Key Findings
9.2. 10.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global Swab and Viral Transport Medium Market Attractiveness Analysis, by Region
10. North America Swab and Viral Transport Medium Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. North America Swab and Viral Transport Medium Market Value Forecast, by Product, 2018–2030
10.2.1. Swab Type
10.2.1.1. Nasal Swabs
10.2.1.2. Nasopharyngeal Swabs
10.2.1.3. Throat Swabs
10.2.2. Transport Medium
10.3. North America Swab and Viral Transport Medium Market Value Forecast, by Application, 2018–2030
10.3.1. Viral Infection Diagnosis
10.3.1.1. COVID-19
10.3.1.2. Influenza
10.3.1.3. Herpes Simplex Virus
10.3.1.4. Varicella-zoster Virus
10.3.1.5. Others
10.3.2. Others
10.4. North America Swab and Viral Transport Medium Market Value Forecast, by End-user, 2018–2030
10.4.1. Hospitals & Clinics
10.4.2. Microbiology Laboratories
10.4.3. Diagnostic Laboratories
10.4.4. Others
10.5. North America Swab and Viral Transport Medium Market Value Forecast, by Country, 2018–2030
10.5.1. U.S.
10.5.2. Canada
10.6. North America Swab and Viral Transport Medium Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Swab and Viral Transport Medium Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Europe Swab and Viral Transport Medium Market Value Forecast, by Product, 2018–2030
11.2.1. Swab Type
11.2.1.1. Nasal Swabs
11.2.1.2. Nasopharyngeal Swabs
11.2.1.3. Throat Swabs
11.2.2. Transport Medium
11.3. Europe Swab and Viral Transport Medium Market Value Forecast, by Application, 2018–2030
11.3.1. Viral Infection Diagnosis
11.3.1.1. COVID-19
11.3.1.2. Influenza
11.3.1.3. Herpes Simplex Virus
11.3.1.4. Varicella-zoster Virus
11.3.1.5. Others
11.3.2. Others
11.4. Europe Swab and Viral Transport Medium Market Value Forecast, by End-user, 2018–2030
11.4.1. Hospitals & Clinics
11.4.2. Microbiology Laboratories
11.4.3. Diagnostic Laboratories
11.4.4. Others
11.5. Europe Swab and Viral Transport Medium Market Value Forecast, by Country/Sub-region, 2018–2030
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe Swab and Viral Transport Medium Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Swab and Viral Transport Medium Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Asia Pacific Swab and Viral Transport Medium Market Value Forecast, by Product, 2018–2030
12.2.1. Swab Type
12.2.1.1. Nasal Swabs
12.2.1.2. Nasopharyngeal Swabs
12.2.1.3. Throat Swabs
12.2.2. Transport Medium
12.3. Asia Pacific Swab and Viral Transport Medium Market Value Forecast, by Application, 2018–2030
12.3.1. Viral Infection Diagnosis
12.3.1.1. COVID-19
12.3.1.2. Influenza
12.3.1.3. Herpes Simplex Virus
12.3.1.4. Varicella-zoster Virus
12.3.1.5. Others
12.3.2. Others
12.4. Asia Pacific Swab and Viral Transport Medium Market Value Forecast, by End-user, 2018–2030
12.4.1. Hospitals & Clinics
12.4.2. Microbiology Laboratories
12.4.3. Diagnostic Laboratories
12.4.4. Others
12.5. Asia Pacific Swab and Viral Transport Medium Market Value Forecast, by Country/Sub-region, 2018–2030
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Asia Pacific Swab and Viral Transport Medium Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Swab and Viral Transport Medium Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Latin America Swab and Viral Transport Medium Market Value Forecast, by Product, 2018–2030
13.2.1. Swab Type
13.2.1.1. Nasal Swabs
13.2.1.2. Nasopharyngeal Swabs
13.2.1.3. Throat Swabs
13.2.2. Transport Medium
13.3. Latin America Swab and Viral Transport Medium Market Value Forecast, by Application, 2018–2030
13.3.1. Viral Infection Diagnosis
13.3.1.1. COVID-19
13.3.1.2. Influenza
13.3.1.3. Herpes Simplex Virus
13.3.1.4. Varicella-zoster Virus
13.3.1.5. Others
13.4. Others
13.5. Latin America Swab and Viral Transport Medium Market Value Forecast, by End-user, 2018–2030
13.5.1. Hospitals & Clinics
13.5.2. Microbiology Laboratories
13.5.3. Diagnostic Laboratories
13.5.4. Others
13.6. Latin America Swab and Viral Transport Medium Market Value Forecast, by Country/Sub-region, 2018–2030
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Latin America Swab and Viral Transport Medium Market Attractiveness Analysis
13.7.1. By Product
13.7.2. By Application
13.7.3. By End-user
13.7.4. By Country/Sub-region
14. Middle East & Africa Swab and Viral Transport Medium Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Middle East & Africa Swab and Viral Transport Medium Market Value Forecast, by Product, 2018–2030
14.2.1. Swab Type
14.2.1.1. Nasal Swabs
14.2.1.2. Nasopharyngeal Swabs
14.2.1.3. Throat Swabs
14.2.2. Transport Medium
14.3. Middle East & Africa Swab and Viral Transport Medium Market Value Forecast, by Application, 2018–2030
14.3.1. Viral Infection Diagnosis
14.3.1.1. COVID-19
14.3.1.2. Influenza
14.3.1.3. Herpes Simplex Virus
14.3.1.4. Varicella-zoster Virus
14.3.1.5. Others
14.3.2. Others
14.4. Middle East & Africa Swab and Viral Transport Medium Market Value Forecast, by End-user, 2018–2030
14.4.1. Hospitals & Clinics
14.4.2. Microbiology Laboratories
14.4.3. Diagnostic Laboratories
14.4.4. Others
14.5. Middle East & Africa Swab and Viral Transport Medium Market Value Forecast, by Country/Sub-region, 2018–2030
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Middle East & Africa Swab and Viral Transport Medium Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2019
15.3. Company Profiles
15.3.1. Thermo Fisher Scientific
15.3.1.1. Company Overview
15.3.1.2. Company Financials
15.3.1.3. Growth Strategies
15.3.1.4. SWOT Analysis
15.3.2. Becton, Dickinson and Company (BD)
15.3.2.1. Company Overview
15.3.2.2. Company Financials
15.3.2.3. Growth Strategies
15.3.2.4. SWOT Analysis
15.3.3. MWE
15.3.3.1. Company Overview
15.3.3.2. Company Financials
15.3.3.3. Growth Strategies
15.3.3.4. SWOT Analysis
15.3.4. Titan Biotech Ltd.
15.3.4.1. Company Overview
15.3.4.2. Company Financials
15.3.4.3. Growth Strategies
15.3.4.4. SWOT Analysis
15.3.5. COPAN Diagnostics, Inc.
15.3.5.1. Company Overview
15.3.5.2. Company Financials
15.3.5.3. Growth Strategies
15.3.5.4. SWOT Analysis
15.3.6. MANTACC
15.3.6.1. Company Overview
15.3.6.2. Company Financials
15.3.6.3. Growth Strategies
15.3.6.4. SWOT Analysis
15.3.7. Puritan Medical Products
15.3.7.1. Company Overview
15.3.7.2. Company Financials
15.3.7.3. Growth Strategies
15.3.7.4. SWOT Analysis
15.3.8. YOCON Biology
15.3.8.1. Company Overview
15.3.8.2. Company Financials
15.3.8.3. Growth Strategies
15.3.8.4. SWOT Analysis
15.3.9. Trinity Biotech
15.3.9.1. Company Overview
15.3.9.2. Company Financials
15.3.9.3. Growth Strategies
15.3.9.4. SWOT Analysis
15.3.10. VIRCELL S.L.
15.3.10.1. Company Overview
15.3.10.2. Company Financials
15.3.10.3. Growth Strategies
15.3.10.4. SWOT Analysis
15.3.11. Other Prominent Key Players
List of Tables
Table: 1 Global Swab and Viral Transport Medium Market Size (US$ Mn) Forecast, by Product, 2018–2030
Table: 2 Global Swab and Viral Transport Medium Market Size (US$ Mn) Forecast, by Application, 2018–2030
Table: 3 Global Swab and Viral Transport Medium Market Size (US$ Mn) Forecast, by End-user, 2018–2030
Table: 4 Global Swab and Viral Transport Medium Market Value (US$ Mn) Forecast, by Region, 2018–2030
Table: 5 North America Swab and Viral Transport Medium Market Size (US$ Mn) Forecast, by Product, 2018–2030
Table: 6 North America Swab and Viral Transport Medium Market Size (US$ Mn) Forecast, by Application, 2018–2030
Table: 7 North America Swab and Viral Transport Medium Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table: 8 North America Swab and Viral Transport Medium Market Value (US$ Mn) Forecast, by Country, 2018–2030
Table: 9 Europe Swab and Viral Transport Medium Market Size (US$ Mn) Forecast, by Product, 2018–2030
Table: 10 Europe Swab and Viral Transport Medium Market Size (US$ Mn) Forecast, by Application, 2018–2030
Table: 11 Europe Swab and Viral Transport Medium Market Revenue (US$ Mn) Forecast, by End-user, 2018–2030
Table: 12 Europe Swab and Viral Transport Medium Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table: 13 Asia Pacific Swab and Viral Transport Medium Market Size (US$ Mn) Forecast, by Product, 2018–2030
Table: 14 Asia Pacific Swab and Viral Transport Medium Market Size (US$ Mn) Forecast, by Application, 2018–2030
Table: 15 Asia Pacific Swab and Viral Transport Medium Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table: 16 Asia Pacific Swab and Viral Transport Medium Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table: 17 Latin America Swab and Viral Transport Medium Market Size (US$ Mn) Forecast, by Product, 2018–2030
Table: 18 Latin America Swab and Viral Transport Medium Market Size (US$ Mn) Forecast, by Application, 2018–2030
Table: 19 Latin America Swab and Viral Transport Medium Market Size (US$ Mn) Forecast, by End-user, 2018–2030
Table: 20 Latin America Swab and Viral Transport Medium Market Size (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table: 21 Middle East & Africa Swab and Viral Transport Medium Market Size (US$ Mn) Forecast, by Product, 2018–2030
Table: 22 Middle East & Africa Swab and Viral Transport Medium Market Size (US$ Mn) Forecast, by Application, 2018–2030
Table: 23 Middle East & Africa Swab and Viral Transport Medium Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table: 24 Middle East & Africa Swab and Viral Transport Medium Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
List of Figures
Figure: 1 Global Swab and Viral Transport Medium Market Value, by Product (US$ Mn), 2019
Figure: 2 Global Swab and Viral Transport Medium Market Share Top Trends, by Product, 2019
Figure: 3 Global Swab and Viral Transport Medium Market Share, by Region, 2019
Figure: 4 Global Swab and Viral Transport Medium Market Share Analysis, by Region
Figure: 5 Global Swab and Viral Transport Medium Market - Porter’s Five Forces Analysis
Figure: 6 Global Swab and Viral Transport Medium Market Value (US$ Mn) and Forecast, 2020–2028
Figure: 7 Global Swab and Viral Transport Medium Market Value Share Analysis, by Region, 2019 and 2030
Figure: 8 Global Swab and Viral Transport Medium Market Attractiveness Analysis, by Region, 2020–2028
Figure: 9 Global Swab and Viral Transport Medium Market Value Share, by Product 2019 and 2030
Figure: 10 Global Swab and Viral Transport Medium Market Attractiveness Analysis, by Product, 2020–2028
Figure: 11 Global Swab and Viral Transport Medium Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Swab Type, 2018–2030
Figure: 12 Global Swab and Viral Transport Medium Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Transport Medium, 2018–2030
Figure: 13 Global Swab and Viral Transport Medium Market Value Share, by Application 2019 and 2030
Figure: 14 Global Swab and Viral Transport Medium Market Attractiveness Analysis, by Application, 2020–2028
Figure: 15 Global Swab and Viral Transport Medium Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Viral Infection Diagnosis, 2018–2030
Figure: 16 Global Swab and Viral Transport Medium Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2018–2030
Figure: 17 Global Swab and Viral Transport Medium Market Value Share, by End user 2019 and 2030
Figure: 18 Global Swab and Viral Transport Medium Market Attractiveness Analysis, by End-user, 2020–2028
Figure: 19 North America Swab and Viral Transport Medium Market Value (US$ Mn) Forecast, 2018–2030
Figure: 20 North America Swab and Viral Transport Medium Market Value Share Analysis, by Country, 2019 and 2030
Figure: 21 North America Swab and Viral Transport Medium Market Attractiveness Analysis, by Country, 2020–2028
Figure: 22 North America Swab and Viral Transport Medium Market Value Share Analysis, by Product, 2019 and 2030
Figure: 23 North America Swab and Viral Transport Medium Market Attractiveness Analysis, by Product, 2019-2027
Figure: 24 North America Swab and Viral Transport Medium Market Value Share Analysis, by Application, 2019 and 2030
Figure: 25 North America Swab and Viral Transport Medium Market Attractiveness Analysis, by Application, 2019-2027
Figure: 26 North America Swab and Viral Transport Medium Market Value Share Analysis, by End-user, 2019 and 2030
Figure: 27 North America Swab and Viral Transport Medium Market Attractiveness Analysis, by End-user, 2019-2027
Figure: 28 Europe Swab and Viral Transport Medium Market Value (US$ Mn) Forecast, 2018–2030
Figure: 29 Europe Swab and Viral Transport Medium Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
Figure: 30 Europe Swab and Viral Transport Medium Market Attractiveness Analysis, by Country/Sub-region, 2020–2028
Figure: 31 Europe Swab and Viral Transport Medium Market Value Share Analysis, by Product, 2019 and 2030
Figure: 32 Europe Swab and Viral Transport Medium Market Attractiveness Analysis, by Product, 2019-2027
Figure: 33 Europe Swab and Viral Transport Medium Market Value Share Analysis, by Application, 2019 and 2030
Figure: 34 Europe Swab and Viral Transport Medium Market Attractiveness Analysis, by Application, 2019-2027
Figure: 35 Europe Swab and Viral Transport Medium Market Value Share Analysis, by End-user, 2019 and 2030
Figure: 36 Europe Swab and Viral Transport Medium Market Attractiveness Analysis, by End-user, 2019-2027
Figure: 37 Asia Pacific Swab and Viral Transport Medium Market Value (US$ Mn) Forecast, 2018–2030
Figure: 38 Asia Pacific Swab and Viral Transport Medium Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
Figure: 39 Asia Pacific Swab and Viral Transport Medium Market Attractiveness Analysis, by Country/Sub-region, 2020–2028
Figure: 40 Asia Pacific Swab and Viral Transport Medium Market Value Share Analysis, by Product, 2019 and 2030
Figure: 41 Asia Pacific Swab and Viral Transport Medium Market Attractiveness Analysis, by Product, 2019-2027
Figure: 42 Asia Pacific Swab and Viral Transport Medium Market Value Share Analysis, by Application, 2019 and 2030
Figure: 43 Asia Pacific Swab and Viral Transport Medium Market Attractiveness Analysis, by Application, 2019-2027
Figure: 44 Asia Pacific Swab and Viral Transport Medium Market Value Share Analysis, by End-user, 2019 and 2030
Figure: 45 Asia Pacific Swab and Viral Transport Medium Market Attractiveness Analysis, by End-user, 2019-2027
Figure: 46 Latin America Swab and Viral Transport Medium Market Value (US$ Mn) Forecast, 2018–2030
Figure: 47 Latin America Swab and Viral Transport Medium Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
Figure: 48 Latin America Swab and Viral Transport Medium Market Attractiveness Analysis, by Country/Sub-region, 2020–2028
Figure: 49 Latin America Swab and Viral Transport Medium Market Value Share Analysis, by Product, 2019 and 2030
Figure: 50 Latin America Swab and Viral Transport Medium Market Attractiveness Analysis, by Product, 2019-2027
Figure: 51 Latin America Swab and Viral Transport Medium Market Value Share Analysis, by Application, 2019 and 2030
Figure: 52 Latin America Swab and Viral Transport Medium Market Attractiveness Analysis, by Application, 2019-2027
Figure: 53 Latin America Swab and Viral Transport Medium Market Value Share Analysis, by End-user, 2019 and 2030
Figure: 54 Latin America Swab and Viral Transport Medium Market Attractiveness Analysis, by End-user, 2019-2027
Figure: 55 Middle East & Africa Swab and Viral Transport Medium Market Value (US$ Mn) Forecast, 2018–2030
Figure: 56 Middle East & Africa Swab and Viral Transport Medium Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
Figure: 57 Middle East & Africa Swab and Viral Transport Medium Market Attractiveness Analysis, by Country/Sub-region, 2020–2028
Figure: 58 Middle East & Africa Swab and Viral Transport Medium Market Value Share Analysis, by Product, 2019 and 2030
Figure: 59 Middle East & Africa Swab and Viral Transport Medium Market Attractiveness Analysis, by Product, 2019-2027
Figure: 60 Middle East & Africa Swab and Viral Transport Medium Market Value Share Analysis, by Application, 2019 and 2030
Figure: 61 Middle East & Africa Swab and Viral Transport Medium Market Attractiveness Analysis, by Application, 2019-2027
Figure: 62 Middle East & Africa Swab and Viral Transport Medium Market Value Share Analysis, by End-user, 2019 and 2030
Figure: 63 Middle East & Africa Swab and Viral Transport Medium Market Attractiveness Analysis, by End-user, 2019-2027
Figure: 64 Thermo Fisher Scientific Revenue (US$ Bn) and Y-o-Y Growth (%), 2019
Figure: 65 Thermo Fisher Scientific Research & Development Expenses, 2019
Figure: 66 Thermo Fisher Scientific Breakdown of Net Sales (% Share), by Business Segment, 2019
Figure: 67 Thermo Fisher Scientific Breakdown of Net Sales (% Share), by Region, 2019
Figure: 68 C. R. Bard, Inc. (Becton, Dickinson and Company) Revenue (US$ Bn) and Y-o-Y Growth (%), 2019
Figure: 69 C. R. Bard, Inc. (Becton, Dickinson and Company) Research & Development Expenses, 2019
Figure: 70 C. R. Bard, Inc. (Becton, Dickinson and Company) Breakdown of Net Sales (% Share), by Business Segment, 2019
Figure: 71 C. R. Bard, Inc. (Becton, Dickinson and Company) Breakdown of Net Sales (% Share), by Region (2019)
Figure: 72 Titan Biotech Ltd Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2019
Figure: 73 Trinity Biotech Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2019
Figure: 74 Trinity Biotech Research and development expenses (US$ Mn) and Y-o-Y Growth (%), 2017–2019
Figure: 75 Trinity Biotech Breakdown of Net Sales (%), by Region, 2019
Figure: 76 Trinity Biotech Breakdown of Net Sales (%), by Business Segment, 2019
